Efficacy and safety of first-line immunotherapy for advanced gastric or gastroesophageal cancer: System review network meta-analysis

被引：0
|
作者：
Qin, Qiong
Sun, Yongkun
Yang, Lin
Zhong, Diansheng
机构：
[1] Tianjin Med Univ, Gen Hosp, Tianjin, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Dept Med Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Natl Clin Res Ctr Canc, Canc Hosp, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16014
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of PD-1 inhibitors combined with chemotherapy as first-line therapy for advanced esophageal cancer: A systematic review and network meta-analysis
    Li, Zi-Chun
    Sun, Yu-Ting
    Lai, Ming-Yu
    Zhou, Yi-Xin
    Qiu, Miao-Zhen
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 109
  • [42] Comparison of Efficacy and Safety of Third-Line Treatments for Advanced Gastric Cancer: A Systematic Review With Bayesian Network Meta-Analysis
    Huang, Miao
    Li, Jisheng
    Yu, Xuejun
    Xu, Qian
    Zhang, Xue
    Dai, Xin
    Li, Song
    Sheng, Lei
    Huang, Kai
    Liu, Lian
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [43] Efficacy and Safety of First-Line Immunotherapy in Combination with Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis
    Wang, Bi-Cheng
    Xiao, Bo-Ya
    Li, Peng-Cheng
    Kuang, Bo-Hua
    Chen, Wang-Bing
    Li, Pin-Dong
    Lin, Guo-He
    Liu, Quentin
    JOURNAL OF ONCOLOGY, 2020, 2020
  • [44] Efficacy of first-line combination therapies versus gemcitabine monotherapy for advanced pancreatic cancer: a systematic review and network meta-analysis
    Huang, Wen-Kuan
    Hung, Yu-Liang
    Tsai, Chun-Yi
    Wu, Chiao-En
    Chou, Wen-Chi
    Hsu, Jun-Te
    Yeh, Ta-Sen
    Chen, Jen-Shi
    Wang, Shang-Yu
    Yeh, Chun-Nan
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (07):
  • [45] Efficacy and safety of the first-line systemic treatments in patients with advanced-stage urothelial carcinoma: a systematic review and network meta-analysis
    Zhao, Yang
    Xu, Xiaoqing
    Sun, Yuhan
    Yu, Xinyang
    Qi, Yuanfu
    Dai, Xin
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [46] Fluoropyrimidine-Based Chemotherapy as First-Line Treatment for Advanced Gastric Cancer: a Bayesian Network Meta-Analysis
    Zhu, Lucheng
    Liu, Jihong
    MA, Shenglin
    PATHOLOGY & ONCOLOGY RESEARCH, 2016, 22 (04) : 853 - 861
  • [47] First-Line Immunotherapy Combinations in Advanced Renal Cell Carcinoma: A Rapid Review and Meta-Analysis
    Shpilsky, Jason
    Catalano, Paul J.
    McDermott, David F.
    KIDNEY CANCER, 2021, 5 (03) : 153 - 163
  • [48] Efficacy and Safety of Various First-Line Therapeutic Strategies for Fetal Tachycardias: A Network Meta-Analysis and Systematic Review
    Qin, Jiangwei
    Deng, Zhengrong
    Tang, Changqing
    Zhang, Yunfan
    Hu, Ruolan
    Li, Jiawen
    Hua, Yimin
    Li, Yifei
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [49] Efficacy and Safety of Sintilimab in Patients With Gastric or Gastroesophageal Junction Cancer: A Systematic Review and Meta-Analysis
    Altaf, Faryal
    Fatima, Eeshal
    Khanzada, Mikail
    Safi, Adnan
    Qureshi, Zaheer
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1679 - S1679
  • [50] Efficacy and safety of first-line treatment for metastatic triple-negative breast cancer: A network meta-analysis
    Shi, Mingqiang
    Li, Zhoujuan
    Shen, Guoshuang
    Wang, Tianzhuo
    Li, Jinming
    Wang, Miaozhou
    Liu, Zhen
    Zhao, Fuxing
    Ren, Dengfeng
    Zhao, Jiuda
    CANCER PATHOGENESIS AND THERAPY, 2024, 2 (02): : 81 - 90
12345